Press-release for stocks publishing date 2021 - 12

Prices are updated after-hours

publishing date : 2021 - 12 - 01 tags : Therapeutics

save search

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-12-01 (Crawled : 00:00) - globenewswire.com
GTHX | $4.12 -1.2% -1.21% 730K

Health Technology

| -68.4% | O: -5.12% H: 3.91% C: -3.67%
therapeutics granted grant

Context Therapeutics Inc. Announces $31.25 Million Private Placement
Published: 2021-12-01 (Crawled : 00:00) - globenewswire.com
CNTX | $1.39 -1.42% -1.44% 5.7K

Health Technology

| -80.31% | O: -20.25% H: 2.63% C: 0.35%
therapeutics

Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-12-01 (Crawled : 23:00) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K

Health Technology

| 219.64% | O: 0.36% H: 3.2% C: 2.14%
therapeutics granted grant

Gain Therapeutics to Participate at the Imagine AI + Healthcare Investor Summit
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
GANX | $3.155 0.16% 0.16% 71K

Professional, Scientific, and T...

| -56.08% | O: 0.14% H: 3.35% C: -2.9%
therapeutics

Qualigen Therapeutics, Inc. Announces Closing of $8.82 Million Registered Direct Offering
Published: 2021-12-01 (Crawled : 21:00) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K

Health Technology

| -79.45% | O: -4.79% H: 1.44% C: -5.04%
offering therapeutics

Akari Therapeutics Presents New Data Revealing Potential Mechanism of Action Driving Serious Exacerbations Across Lung Disorders
Published: 2021-12-01 (Crawled : 20:00) - akaritx.com
AKTX | $1.11 -8.26% -9.01% 3.7K

Health Technology

| -29.11% | O: 3.07% H: 1.19% C: -1.19%
order therapeutics potential

Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-01 (Crawled : 17:00) - globenewswire.com
HOWL | $5.91 0.68% 0.68% 120K

Professional, Scientific, and T...

| -59.49% | O: 3.66% H: 0.0% C: -8.79%
ema therapeutics preclinical pre-clinical

Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
RLMD | $4.0 -6.98% -7.5% 150K

Health Technology

| -73.8% | O: 2.35% H: 0.0% C: -6.4%
therapeutics

Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney Disease Drug Development Summit
Published: 2021-12-01 (Crawled : 14:30) - biospace.com/
RGLS | $2.13 -4.05% -4.23% 220K

Health Technology

| 472.9% | O: -1.94% H: 1.32% C: -4.71%
genetic drug therapeutics presentation disease kidney rare

Allogene Therapeutics Announces Conference Call to Review ALPHA, ALPHA2 and UNIVERSAL Phase 1 Data Presented at the 2021 American Society of Hematology Annual Meeting
Published: 2021-12-01 (Crawled : 14:00) - biospace.com/
ALLO | $3.48 0.58% 0.57% 2M

Health Technology

| -80.19% | O: 3.34% H: 5.42% C: -0.27%
ema conference therapeutics phase 1

Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
Published: 2021-12-01 (Crawled : 13:30) - biospace.com/
VIRI | $0.4393 -2.36% -2.41% 59K

Health Technology

| -90.66% | O: 14.52% H: 0.0% C: -8.15%
phase 2 phase 2b fibromyalgia trial therapeutics enroll milestone

SAB Biotherapeutics Announces SAB-176 Met its Primary Endpoint in Phase 2a Challenge Study in Adults Infected with Influenza Virus
Published: 2021-12-01 (Crawled : 13:30) - biospace.com/
SABS | $4.46 0.22% 890

| -57.09% | O: 1.77% H: 10.82% C: 3.02%
phase 2 therapeutics influenza iot sab-176 diversitab infections phase 2b

Parthenon Therapeutics Appoints Tamas Oravecz, Ph.D., as Chief Scientific Officer
Published: 2021-12-01 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.55% | O: -1.03% H: 2.04% C: 0.76%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -11.0% | O: -0.66% H: 0.0% C: 0.0%
therapeutics vtama

Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care Program
Published: 2021-12-01 (Crawled : 13:00) - globenewswire.com
ARTH | $1.18 -17.78% 6.9K

Manufacturing

| 1033.37% | O: 0.0% H: 1.32% C: 1.32%
therapeutics wound care diabetic diabetes

Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvantaged Students in Ireland Further Their STEM Education
Published: 2021-12-01 (Crawled : 12:30) - biospace.com/
HZNP | $116.3 0.03% 29M

Health Technology

| 14.85% | O: 3.24% H: 3.08% C: 0.87%
therapeutics education

BioXcel Therapeutics Announces Extension of FDA Review Period of its NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K

Health Technology

| -88.28% | O: -13.2% H: 11.23% C: 8.21%
treatment fda schizophrenia order therapeutics

G1 Therapeutics Initiates Phase 2 Trial to Support the Antitumor Mechanism of Action (MOA) of Trilaciclib in the Tumor Microenvironment
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
GTHX | $4.12 -1.2% -1.21% 730K

Health Technology

| -66.37% | O: 6.41% H: 0.0% C: 0.0%
phase 2 trilaciclib trial therapeutics

Silence Therapeutics Welcomes Deep Track Capital as New Shareholder
Published: 2021-12-01 (Crawled : 12:30) - globenewswire.com
SLNCF | $8.0 -65.0% 630

Health Technology